| Patents for C07D 213 - Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members (63,273) |
|---|
| 09/30/2004 | DE10310887A1 Matallkomplexe Matallkomplexe |
| 09/30/2004 | CA2519582A1 Substituted p-diaminobenzene derivatives |
| 09/30/2004 | CA2519022A1 2-(butyl-1-sulfonylamino)-n-[1(r)-(6-methoxy-pyridin-3-yl)-propyl]-benzamid, the use thereof in the form of drug an pharmaceutical preparations containing said compound |
| 09/29/2004 | EP1461345A2 Copper deposition using copper formate complexes |
| 09/29/2004 | EP1461323A2 Compounds for the treatment of metabolic disorders |
| 09/29/2004 | EP1461313A1 Human adam-10 inhibitors |
| 09/29/2004 | EP1461311A2 Urea derivatives as vr1-antagonists |
| 09/29/2004 | EP1461310A1 Bacterial enzyme inhibitors |
| 09/29/2004 | EP1461038A1 Arylsulfonamide derivatives for use as ccr3 antagonists in the treatment of inflammatory and immunological disorders |
| 09/29/2004 | EP1189881B1 Propanoic acid derivatives that inhibit the binding of integrins to their receptors |
| 09/29/2004 | EP1176960B1 Synergistic combination comprising roflumilast and a pde-3 inhibitor |
| 09/29/2004 | EP0766671B1 Tetra-substituted phenyl derivatives useful as pde iv inhibitors |
| 09/29/2004 | EP0736016B1 Trisubstituted phenyl derivatives, processes for their preparation and their use as phosphodiesterase (type iv) inhibitor |
| 09/29/2004 | CN1533382A 哌嗪衍生物 Piperazine derivatives |
| 09/29/2004 | CN1533379A A short synthesis of pyridine-based pharmaceutical intermediates with salfur-containing groups at the 2-and 3-positions |
| 09/29/2004 | CN1533378A Process for production of quinazolines |
| 09/29/2004 | CN1533374A Substitutled cyclohexane-1,4-diamine derivatives |
| 09/29/2004 | CN1533270A Oral administered dosage form of GABA anolog prodrugs having reduced toxicity |
| 09/29/2004 | CN1168719C 6-phenylpyridyl-2-amine derivatives and pharmaceutical composition and use |
| 09/29/2004 | CN1168718C Process for preparation of 2-(6-substituted pyrid-2-yloxymethyl) phenylacetate |
| 09/29/2004 | CN1168709C Alpha-hydroxy, amino and fluoro derivatives of beta-sulphenyl hdyroxamic acids matrix metalloproteinase inhibitors |
| 09/29/2004 | CN1168707C 4-guanidinobenzamides antifertility compounds |
| 09/29/2004 | CN1168704C Aryl and heteroaryl cyclopropyl oximidoether and its application as bactericide and pesticide |
| 09/28/2004 | US6797848 Anthracene derivative and organic electroluminescence device using the derivative |
| 09/28/2004 | US6797731 Resorcinol derivatives |
| 09/28/2004 | US6797716 Imidazonaphthyridines |
| 09/28/2004 | US6797715 Analogues of camptothecin, their use as medicaments and the pharmaceutical compositions containing them |
| 09/28/2004 | US6797706 Heterocyclecarboxamide derivative |
| 09/28/2004 | CA2299013C Neuropeptide y antagonists |
| 09/28/2004 | CA2224125C Pharmaceutical composition comprising a proteinase inhibitor and a monoglyceride |
| 09/28/2004 | CA2155572C Piperazinylpyridinyl water clathrates |
| 09/23/2004 | WO2004081643A1 Lenslet array with polarization conversion |
| 09/23/2004 | WO2004081019A1 Organic metal complex, electroluminescent material using the complex and ectroluminescent element using the complex |
| 09/23/2004 | WO2004081017A1 Metal complexes |
| 09/23/2004 | WO2004080974A1 A purification method of ionic liquids to obtain their high purity |
| 09/23/2004 | WO2004080968A1 6-substituted nicotinamide derivatives as opioid receptor antagonists |
| 09/23/2004 | WO2004080967A1 Novel process for the preparation of roflumilast |
| 09/23/2004 | WO2004080947A1 Imino ether derivative compounds and drugs containing the compounds as the active ingredient |
| 09/23/2004 | WO2004080377A2 Kcnq channel modulating compounds and their pharmaceutical use |
| 09/23/2004 | WO2004080376A2 Hydroxyethylamine compounds having asp2 inhibitory activity for the treatment of alzheimer’s disease |
| 09/23/2004 | WO2004050613A3 2-substituted-3-propenamide derivatives and methods of using the same |
| 09/23/2004 | WO2004005472A3 Inhibitors of ftsz and uses thereof |
| 09/23/2004 | US20040186301 Derivatives of succinic and glutaric acids and analogs thereof useful as inhibitors of phex |
| 09/23/2004 | US20040186297 Process for conversion of cyanopyridines to nicotinamides and catalyst therefor, process for preparing said catalyst |
| 09/23/2004 | US20040186290 transferase enzyme modulators such as 2-(6-Chloropyridin-3-yl)-3-cyclopentyl-N-thiazol-2-ylpropionamide, used for prophylaxis of hyperglycemia and diabetes |
| 09/23/2004 | US20040186154 treating or preventing a hypercholesterolemia-related or an inflammation-related condition ; apical sodium co-dependent bile acid transport inhibitor and an amount of a cyclooxygenase-2 (COX-2) selective inhibitor or its prodrug; kits |
| 09/23/2004 | US20040186148 E.g., 1-(pyrid-2-yl-so2-),2-((4-(isopropylphenyl)-so2-),5-(isopropoxy)benzene; antiinflammatory agents; immunomodulatory activity rheumatoid arthritis, asthma, allergy, psoriasis, Crohn's disease, systemic lupus erythematosus, multiple sclerosis, diabetes, cancer, glaucoma, osteoporosis, renal ischemia |
| 09/23/2004 | US20040186146 E.g., R-N-2-[4-(pyrrolidin-1'-yl)methylphenyl]propionyl-methanesulfonamide; inhibition of chemotaxis of neutrophils induced by interleukin-8; antiinflammatory agents; psoriasis, ulcerative cholitis, glomerular nephritis, acute respiratory insufficiency, idiopathic fibrosis, and rheumatoid arthritis |
| 09/23/2004 | US20040186145 Sulfur substituted sulfonylaminocarboxylic acid N-arylamides, their preparation, their use and pharmaceutical preparations comprising them |
| 09/23/2004 | US20040186144 Use of vitamin B6 to mitigate visual field defects associated with the use of GABAergic drugs in mammals |
| 09/23/2004 | US20040186133 preferably antagonists used in the therapeutic and/or preventive treatment of disfunctions of the heart, kidney, respiratory system, central nervous system |
| 09/23/2004 | US20040186113 Heterocyclic amines for the treatment of conditions associated with gsk-3 |
| 09/23/2004 | US20040186104 Novel pyridinone and related heterocyclic derivatives |
| 09/23/2004 | US20040186100 X-ray diffraction patterning; for treatment of migraine, rheumatoid arthritis, asthma, bronchial hyperreactivity, allergic rhinitis, ocular inflammatory diseases, and oedema; for treating drug abuse |
| 09/23/2004 | US20040186080 Beta 2-adrenergic receptor agonists |
| 09/23/2004 | US20040186078 Substituted N'-(arylcarbonyl)-benzhydrazides, N'-(arylcarbonyl)-benzylidene-hydrazides and analogs as activators of caspases and inducers of apoptosis and the use thereof |
| 09/23/2004 | US20040186007 Monometallic azo complexes of late transition metals for the polymerization of olefins |
| 09/23/2004 | CA2518986A1 Imino ether derivative compounds and drugs containing the compounds as the active ingredient |
| 09/23/2004 | CA2518194A1 6-substituted nicotinamide derivatives as opioid receptor antagonists |
| 09/22/2004 | EP1460074A1 Substituted amino alkyl compounds |
| 09/22/2004 | EP1459746A1 The use of vitamin B6 to mitigate visual field defects associated with the use of GABAergic drugs in mammals |
| 09/22/2004 | EP1459743A2 Agent for prophylaxis and treatment of glaucoma |
| 09/22/2004 | EP1459742A2 Agent for prophylaxis and treatment of asthenopia and pseudomyopia |
| 09/22/2004 | EP1458731A1 Chiral ligands for asymmetric catalysis |
| 09/22/2004 | EP1458719A1 Pyridoquinoxaline antivirals |
| 09/22/2004 | EP1458686A1 Benzocyclodecane derivatives with antitumor activity |
| 09/22/2004 | EP1458685A2 Substituted phenyl derivatives |
| 09/22/2004 | EP1458684A2 Therapeutic heterocycles |
| 09/22/2004 | EP1458683A1 Heteroaryl-substituted aminocyclohexane derivatives |
| 09/22/2004 | EP1458676A2 Compounds for the treatment of inflammatory disorders |
| 09/22/2004 | EP1458382A1 Amide derivatives as gk activators |
| 09/22/2004 | EP1458375A2 Compositions for decreasing activity of hormone-sensitive lipase |
| 09/22/2004 | EP1458374A2 Compounds and uses thereof for decreasing activity of hormone-sensitive lipase |
| 09/22/2004 | EP1153014B1 Beta-alanine derivatives |
| 09/22/2004 | EP1100503B1 Non-imidazole alkylamines as histamine h 3?-receptor ligands and their therapeutic applications |
| 09/22/2004 | EP1060174B1 Nitric oxide releasing chelating agents and their therapeutic use |
| 09/22/2004 | EP1040112B1 Imidazonaphthyridines and their use in inducing cytokine biosynthesis |
| 09/22/2004 | EP0623133B1 Substituted amino alkyl compounds |
| 09/22/2004 | CN1531534A 2-heteroaryl-3,4-dihydro-2H-pyrrole derivatives and use thereof as pesticides |
| 09/22/2004 | CN1531525A Organic compounds |
| 09/22/2004 | CN1531433A Synergistic pharmaceutical combination for prevention or treatment of diabetes |
| 09/22/2004 | CN1531425A Urea derivatives as integrin alpha 4 antagonists |
| 09/22/2004 | CN1168099C Ionic liquids as solvents |
| 09/22/2004 | CN1167785C Bleaching composition and method for bleaching sustrate |
| 09/22/2004 | CN1167684C Non-ball shaped and non-flake type mercapto pyridine oxide salts and prepn. method therefor |
| 09/22/2004 | CN1167670C Aryl carboxylic acid and tetrazole derivant |
| 09/21/2004 | US6794515 Synthesis of 2-alkylcysteine via substituted thiazoline amide |
| 09/21/2004 | US6794513 Preparation of 3,6-dichloro-2-trichloromethylpyridine by vapor phase chlorination of 6-chloro-2-trichloromethylpyridine |
| 09/21/2004 | US6794511 An enzyme inhibitors of metalloprotease; treating connective tissue degradation caused by inflammation or tumor |
| 09/21/2004 | US6794507 Compounds that inhibit factor Xa activity |
| 09/21/2004 | US6794400 4-substituted-1-(arylmethylidene)thiosemicarbazide, 4-substituted-1-(arylcarbonyl)thiosemicarbazide and analogs as activators of caspases and inducers of apoptosis and the use thereof |
| 09/21/2004 | US6794398 Preventive/remedies for liver diseases |
| 09/21/2004 | US6794397 Substituted nicotinamides and analogs as activators of caspases and inducers of apoptosis and the use thereof |
| 09/21/2004 | US6794392 Cell differentiation inducer |
| 09/21/2004 | US6794380 Amide derivatives |
| 09/21/2004 | US6794378 Heterocyclic compounds and medical use thereof |
| 09/21/2004 | US6794377 Ortho, ortho-substituted nitrogen-containing bisaryl compounds, useful for the treatment and prophylaxis of atrial arrhymias, e.g. atrail fibrillation or atrial flutters |
| 09/21/2004 | US6794365 Inhibitors of the blood clotting enzyme factor xa; treating thromboembolic diseases; trifluoroacetic acid salt of 2-(4-carbamimidoyl-benzyl)-n-((1-carbamoyl-4-guanidino-butylcarbamoyl) -cyclohexyl-methyl)-n',n'-dimethyl-malonamide |
| 09/21/2004 | US6794336 Herbicidal substituted pyridines, their preparation, and their use as herbicides and plant growth regulators |
| 09/17/2004 | CA2457989A1 The use of vitamin b6 to mitigate visual field defects associated with the use of gabaergic drugs in mammals |